Asters provided legal advice to the global healthcare leader Eli Lilly and Company on Ukrainian merger control law issues, including obtaining merger and antitrust clearances from the Ukrainian competition authority for the approx. USD 5.4 billion acquisition by Eli Lilly and Co. of Novartis' Animal Health business.
The transaction is aimed to strengthen and diversify Eli Lilly's own animal health unit. Upon completion of the acquisition, Elanco will become the second-largest animal health company in terms of global revenue.
Asters team advising on the project included Igor Svechkar, Sergiy Glushchenko, Anastasia Usova, and Igor Smolyak.